Evaluation of States in Major Depressive Patients With Cancer, Hospitalized in a Hospital Palliative
NCT ID: NCT01593085
Last Updated: 2013-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2012-04-30
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cancer and Disorders of Cognitive Functions and Quality of Life: "Cognitive Rehabilitation in Patients Suffering From Cancer and Treated With Chemotherapy"
NCT01788618
Integration of Palliative Care in an Oncology and Hematology Unit
NCT04089306
Incidence and Risk Factors of Prolonged Grief in Palliative Care Units
NCT03748225
Oral Therapies in Oncology: Cognitive Function and Compliance
NCT01597284
Impact of an Intervention Combining Self-care and Hypnosis on the Well-being of Cancer Patients and Their Partners
NCT03144154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients in palliative cares
patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)
interview with a doctor for evaluating suicide risk
patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)
\--------------------------------------------------------------------------------
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
interview with a doctor for evaluating suicide risk
patients with cancer in palliative cares An interview and will be offered to this patient during his hospitalization to be held (with the collection of personal and family psychiatric history of the patient, family and social context, the assessment of chronic pain and fatigue and quality of life,assessment of anxiety, Evaluation of symptoms of depression,asessment of suicide risk)
\--------------------------------------------------------------------------------
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient (s) reach (s) of a cancer palliative stage
* Patient (s) hospital (s) in the palliative care service
* Patient (s) with cognitive function to an interrogation
* Patient (s) having a physical condition for an interview lasting 45 minutes
* Patient (s) that received clear information on the diagnosis and prognosis of their disease.
* Free and informed consent signed
Exclusion Criteria
* Patient (s) under supervision or unable to give informed consent
* Patient (s) whose cognitive functions do not allow an examination.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Francois Baclesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie-Christine GRACH, MD
Role: PRINCIPAL_INVESTIGATOR
Centre François Baclesse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre François BACLESSE
Caen, Calvados, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DECAPAL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.